Glomerular dysfunction, independent of tubular dysfunction, induced by antineoplastic chemotherapy in children

Pediatrics International

Volumn 46, Issue 5, 2004, Pages 570-575

  Ikarashi, Yukie ^a   Kakihara, Toshio ^a   Imai, Chihaya ^a   Tanaka, Atsushi ^a   Watanabe, Akihiro ^b   Uchiyama, Makoto ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA CANCER CENTER HOSPITAL   (Japan)

Author keywords

Antineoplastic agents; Children; Glomerular dysfunction; Side effect; Urinary albumin

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; ASPARAGINASE; BETA 2 MICROGLOBULIN; CISPLATIN; CREATININE; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; N ACETYL BETA GLUCOSAMINIDASE; PEPLEOMYCIN; PIRARUBICIN; PREDNISOLONE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GLOMERULAR DYSFUNCTION; HUMAN; KIDNEY DISEASE; KIDNEY TUBULE DISORDER; KIDNEY TUBULE FUNCTION; LYMPHOMA; NEUROBLASTOMA; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RHABDOMYOSARCOMA; SIDE EFFECT; URINALYSIS;

ACUTE DISEASE; ADOLESCENT; ALBUMINURIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHILD; CHILD, PRESCHOOL; CREATININE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY TUBULES; LEUKEMIA; LYMPHOMA; METHOTREXATE; NEOPLASMS; NEUROBLASTOMA; OSTEOSARCOMA; PROTEINURIA; RHABDOMYOSARCOMA; VINCRISTINE;

EID: 7044264910     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2004.01958.x     Document Type: Article

References (30)

1. Rieselbach RE, Gamik MB. Renal diseases induced by anti-neoplastic agents. Disease of the Kidney, Little Brown, Boston, 1993.
2. Berns JS, Ford AP. Renal toxicities of antineoplastic drugs. Renal toxicities of antineoplastic drugs and bone marrow transplantation. Semin. Nephrol. 1997; 17: 54-66.
3. Shore R, Greenberg M, Geary D, Koren G. Iphosphamide-induced nephrotoxicity in children. Pediatr. Nephrol. 1992; 6: 162-5.
4. Heney D, Wheeldon J, Rushworth P, Chapman C, Lewis IJ, Bailey CC. Progressive renal toxicity due to ifosfamide. Arch. Dis. Child. 1991; 66: 966-70.
5. Harmon WE, Cohen HJ, Schneeberger EE, Grupe WE. Chronic renal failure in children treated with methyl CCNU. N. Engl. J. Med. 1979; 300: 1200-3.
6. Whiteside C, Prutis K, Cameron R, Thompson J. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis. Lab. Invest. 1989; 61: 650-60.
7. Elger M, Kriz W. The renal glomerulus - the structural basis of ultrafiltration. In: Davidson AM, Cameron JS, Grunfeld JP, Kerr DNS, Ritz E, Winearls CG (eds). Oxford Textbook of Clinical Nephrology, 2nd edn. Oxford University Press, Oxford 1998; 361-74.
8. Fioretto P, Maouer M. Glomerular changes in normo- and microalbuminuric patients with long standing insulindependent diabetes mellitus. Adv. Nephrol. Necker. Hosp. 1997;26:247-63.
9. Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983; 32: 64-78.
10. Koizumi S, Fujimoto T. Improvement in treatment of childhood acute lymphoblastic leukaemia: a 10-year study by the Children's Cancer and Leukemia Study Group. Int. J. Hematol. 1994; 59: 99-112.
11. Katano N, Tsurusawa M, Hirota T et al. Treatment outcome and prognostic factors in childhood acute myeloblastic leukemia: a report from the Japanese Children's Cancer and Leukemia Study Group (CCLSG). Int. J. Hematol. 1997; 66: 103-10.
12. Rosen G, Nirenberg A. Neoadjuvant chemotherapy for osteogenic sarcoma: a 5-year follow up (T-10) and preliminary report of new studies (T-12). Pro. Clin. Biol. Res. 1985; 201: 39-51.
13. Tsurusawa M, Katano N, Hirota T et al. Studies of childhood non-Hodgkin's lymphoma treatment results with the CCLSG NHL 960 protocol. Rinsho Ketsueki 1998; 39: 1092-7 (in Japanese).
14. Sawaguchi S, Kaneko M, Uchino J et al. Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy. A report from the Study Group of Japan. Cancer 1990; 66: 1879-87.
15. Kinner R, Pearson ADJ, English MW et al. Risk factors for ifosfamide nephrotoxicity in children. Lancet 1996; 348: 578-80.
16. De Shepper J, Hachimi-Idrissi S, Verboven M, Piepsz A, Otten J. Renal function abnormalities after ifosfamide treatment in children. Acta Pediatr. 1993; 82: 373-6.
17. Burk CD, Restanio I, Kaplan BS, Meadows AT. Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor. J. Pediatr. 1990; 117: 331-5.
18. Skinner R, Pearson ADJ, Coulthard MG et al. Assessment of chemotherapy-associated nephrotoxicity in children with cancer. Cancer Chemother. Pharmacol. 1991; 28: 81-92.
19. Kofoed-Enevaldsen A. Heparan salphate in the pathogenesis of diabetic nephropathy [review]. Diabetes Metab. Rev. 1995; 11: 137-60.
20. Pedrinelli R, Giampietro O, Carmassi F et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14-8.
21. Laurens W, Battaglia C, Foglieni C et al. Direct podocyte damage in the single nephron leads to albuminuria in vivo. Kidney Int. 1995; 47: 1078-86.
22. Hua MJ, Kun HY, Jie CS, Yun NZ, De WQ, Yang Z. Urinary microalbumin and retinol-binding protein assay for verifying children's nephron development and maturation. Clin. Chem. Acta 1997; 264: 127-32.
23. Seiler MW, Rennke HG, Venatachalam MA, Cotran RS. Pathogenesis of polycation-induced alteration's 'fusion' of glomerular epithelium. Lab. Invest. 1977; 36: 48-61.
24. Andrews P. Morphological alterations of the glomerular (visceral) epithelium in response to pathological and experimental situations. J. Electron. Microsc. Tech. 1988; 9: 115-44.
25. Watanabe A, Kakihara T, Hara M et al. Morphological differences between glomerular epithelial cells (GEC) excreted during chemotherapy with antineoplastic drugs and GEC excreted in renal diseases. Pediatr. Int. 2001; 43: 587-91.
26. Rennke HG. How does glomerular epithelial cell injury contribute to progressive glomerular damage? Kidney Int. 1994;45:s58-63.
27. Hara M, Yanagihara T. Clinical and pathological estimation of renal podocyte injury. Jin Toseki 1997; 43: 235-41 (in Japanese).
28. Fajardo LF, Eltringham JR, Stewart JR, Klauber MR. Adriamycin nephrotoxicity. Lab. Invest. 1980; 43: 242-53.
29. Narins RG, Carley M, Bloom EJ, Harrison DS. The nephrotoxicity of chemotherapeutic agents. Semin Nephrol. 1990; 10: 556-64.
30. Harmon WE, Cohen HJ, Schneeberger EE, Grupe WE. Chronic renal failure in children treated with methyl CCNU. N. Engl. J. Med. 1979; 300: 1200-3.